Johnson & Johnson Stock Upgraded Despite $8 Billion Risperdal Verdict: What You Need to Know

Johnson & Johnson (NYSE: JNJ) is a massive medical products conglomerate. But skimming through the headlines it's been producing lately, you'd almost think it was a law firm -- a really bad law firm, that loses a lot of cases: